Email to a Colleague
Medscape Conference Coverage, based on selected sessions at the:
American Transplant Congress 2005: 6th Annual Joint Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation
May 21 - 25, 2005, Seattle, Washington

This activity is not sanctioned by, nor a part of, the American Society of Transplant Surgeons or the American Society of Transplantation.


Also On This Page:Expert InterviewConference News
Topic Overviews
Immunosuppression Minimization and Withdrawal: Are We There Yet? CME/CE
Physicians - up to 1.0 hour(s) of AMA PRA category 1 credit;
Pharmacists - up to 1.0 contact hour(s) (0.1 CEUs);
Registered Nurses - up to 1.2 Nursing Continuing Education contact hour(s)
Advances in Corticosteroid-Sparing Immunosuppression in Renal Transplantation
Ron Shapiro, MD
Optimizing Immunosuppression: Toward Improved Outcomes After Kidney Transplantation
Robert S. Gaston, MD
Induction Therapies for Kidney Transplantation
Daniel C. Brennan, MD, FACP
Pediatric Kidney and Liver Transplantation: Cause for Optimism CME
Physicians - up to 0.5 hour(s) of AMA PRA category 1 credit
Corticosteroid-Sparing Immunosuppression in Pediatric Renal Transplantation
Minnie Sarwal, MBBS, DCH, MRCP, PhD
Outcomes in Pediatric Liver Transplantation: More Encouraging Than Ever
George V. Mazariegos, MD, FACS
Current Issues and Controversies in Transplantation CME/CE
Physicians - up to 1.0 hour(s) of AMA PRA category 1 credit;
Pharmacists - up to 1.0 contact hour(s) (0.1 CEUs);
Registered Nurses - up to 1.2 Nursing Continuing Education contact hour(s)
A Rational Approach to Organ Allocation in 2005
Gwen Mayes, JD, MMSc
Controversies and Realities of Living Kidney Donation
Gwen Mayes, JD, MMSc
Pancreas Transplantation: Progress and Controversies
Robert J. Stratta, MD
Expert Interview
Corticosteroid-Sparing Regimens in Renal Transplantation: An Expert Interview With Herwig-Ulf Meier-Kriesche, MD
Which immunosuppressive protocols -- at the moment -- have shown the feasibility or the possibility of safe steroid avoidance as opposed to steroid withdrawal?
Conference News
Alemtuzumab Effective for Kidney Transplantations 6/1/05
[Medscape Medical News]
The agent significantly reduced the risk of early rejection, according to a retrospective study.
Smoking Linked to Acute Rejection of Kidney Transplant 5/31/05
[Medscape Medical News]
Smokers had a 24% greater risk of acute rejection than nonsmokers, according to researchers.
Hepatitis-Positive Livers Are Safe to Use in Hepatitis-Positive Transplant Recipients 5/26/05
[Medscape Medical News]
Outcomes are equally good for patients receiving hepatitis-positive and hepatitis-negative organs.
Kidney Transplant Grafts Are Surviving Longer 5/26/05
[Medscape Medical News]
Three-year graft survival rate increases from 63% to 78%, according to researchers.
Expanding Criteria for Kidney Donor Has Not Harmed Outcome 5/26/05
[Medscape Medical News]
Patient and kidney graft survival rates are similar, according to researchers.
HIV-Positive Patients Are Good Transplant Candidates 5/25/05
[Medscape Medical News]
Five-year patient and graft survival rates for HIV-positive patients are equivalent to those of HIV-negative recipients.
Belatacept, an Effective Immunosupressant for Kidney Transplant 5/24/05
[Medscape Medical News]
In a randomized trial, chronic allograft nephropathy was significantly reduced.

 
Legal Disclaimer
The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the American Society of Transplant Surgeons or the American Society of Transplantation. These materials and the related activity are not sanctioned by the American Society of Transplant Surgeons or the American Society of Transplantation or the commercial supporter of the conference, and do not constitute an official part of that conference.
The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.
Copyright © 2005 Medscape.

 


Astellas

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.